10-QPeriod: Q3 FY2020

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2020

Filed November 2, 2020For Securities:UNH

Summary

UnitedHealth Group's third quarter 2020 results demonstrate resilience and growth despite the ongoing COVID-19 pandemic. The company reported an 8% increase in total revenues to $65.1 billion for the quarter, driven by strong performance in its Optum segment, which saw a 21% revenue increase, and a 5% rise in UnitedHealthcare revenues. Despite a 7% decrease in consolidated earnings from operations, largely due to COVID-19 related impacts on UnitedHealthcare (down 22%), the company's overall financial position remains robust. Net earnings attributable to common shareholders were $3.17 billion for the quarter, leading to diluted earnings per share of $3.30. The company also generated substantial cash flow from operations of $16.1 billion for the nine months ended September 30, 2020, indicating strong operational liquidity and financial health.

Financial Highlights

55 data points
Beta

Revenue

$65.11B

87.8% Gross Margin

Net Income

$3.17B

4.9% Net Margin

EPS (Diluted)

$3.30

Total Assets

$190.97B

Cash & Equivalents

$17.55B

Free Cash Flow

$2.57B

Financial Statements
Beta
Revenue$65.11B
Cost of Revenue$7.93B
Gross Profit$57.18B
SG&A Expenses$10.17B
Operating Expenses$60.46B
Operating Income$4.65B
Interest Expense$395.00M
Net Income$3.17B
EPS (Basic)$3.34
EPS (Diluted)$3.30
Shares Outstanding (Basic)950.00M
Shares Outstanding (Diluted)962.00M

Key Highlights

  • 1Total revenues increased by 8% year-over-year to $65.1 billion in Q3 2020.
  • 2Optum segment revenue grew by a significant 21%, showcasing strong performance in health services.
  • 3UnitedHealthcare revenue saw a 5% increase, supported by growth in Medicare Advantage and Medicaid programs.
  • 4Net earnings attributable to common shareholders were $3.17 billion, with diluted EPS of $3.30 for the quarter.
  • 5Cash flow from operations for the nine months ended September 30, 2020, was a strong $16.1 billion.
  • 6The company maintained a healthy debt-to-equity ratio below the 60% covenant threshold.
  • 7UnitedHealth Group increased its quarterly cash dividend to $5.00 annually, reflecting confidence in its financial stability.

Frequently Asked Questions

COVID-19 had a mixed impact. While temporary deferral of care negatively affected UnitedHealthcare's earnings, leading to a 22% decrease in operating earnings for the segment, this was partially offset by increased demand for COVID-19 related care and testing, as well as strong growth in Optum. The overall effect was a 7% decrease in consolidated earnings from operations for the quarter.

Revenue growth was primarily driven by the Optum segment, which increased by 21%, and UnitedHealthcare, which grew by 5%. UnitedHealthcare's growth was supported by increased enrollment in Medicare Advantage and Medicaid programs, while Optum's expansion was seen across its health services businesses, including pharmacy care services and care delivery.

UnitedHealth Group maintains strong liquidity, with $17.6 billion in cash and cash equivalents as of September 30, 2020. The company also has significant investment assets and access to substantial credit facilities. Its debt-to-debt-plus-shareholders' equity ratio was approximately 38% as of September 30, 2020, well within its 60% covenant limit, indicating a healthy financial condition.

The company anticipates that increased consumer demand for care, potentially higher acuity care, and continued COVID-19 care and testing costs will lead to increased future medical costs. Disrupted care patterns due to the pandemic may also temporarily affect the ability to obtain complete member health status information, impacting future revenue in risk adjustment businesses. The overall impact remains uncertain and depends on the pandemic's trajectory and economic recovery.